Nachrichten

Aktie

ISIN: US03771D1028 WKN: A4127V SYM: APUS Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

3,2700

USD

+17,20 %

+0,4800 USD

Letzter Kurs 15.11.25 NYSE Arca

Apimeds Pharmaceuticals US Aktie kaufen

Geldkurs

14.11.25

3,2100

USD

100 STK

Briefkurs

14.11.25

3,3400

USD

100 STK

Neueste Nachrichten

Apimeds Brings ai² Futures Lab to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation 10.11.25 · Business Wire (engl.) · Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab Program collaboration with the University of Oregon’s Lundquist College of Business 14.10.25 · Business Wire (engl.) · Apimeds Pharmaceuticals US
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development 16.09.25 · Business Wire (engl.) · Apimeds Pharmaceuticals US
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program 12.09.25 · Business Wire (engl.) · Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs 25.08.25 · Business Wire (engl.) · Apimeds Pharmaceuticals US
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division 15.07.25 · Business Wire (engl.) · Novartis
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering 12.05.25 · globenewswire · Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering 08.05.25 · globenewswire · Apimeds Pharmaceuticals US

Apimeds Brings ai² Futures Lab to the Palouse — Partnering with the University of Idaho to Shape ... 116 Leser

Apimeds Brings ai² Futures Lab to the Palouse — Partnering with the University of Idaho to Shape ... 116 Leser

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech ... 148 Leser
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters ... 140 Leser
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering 140 Leser
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program 124 Leser
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business ... 124 Leser
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab Program collaboration ... 120 Leser
Apimeds Brings ai² Futures Lab to the Palouse — Partnering with the University of Idaho to Shape ... 116 Leser
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering 116 Leser